CEACAM7 (BAC2) Antibody sc-59946 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Pathogenesis of adherent-invasive Escherichia coli LF82 in human colonic epithelium is characterized by adhesive biofilms, mucus penetration, and contact-dependent cytotoxicityGut MicrobesDecember 31, 2025Bethan Fay Evans, Tshering Dorji, Damira Bigaliyeva, Simon Chan, Stephanie Schüller(sc-23928, Santa Cruz), anti-CEACAM6 (sc-59899, Santa Cruz; 17169525, Invitrogen), and anti-CEACAM7 (sc-59946, Santa Cruz) at a dilution of 1:100 for 1 h before bacterial inoculation. To block bacterial invasion,

(2) CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal AdenocarcinomaClinical cancer research : an official journal of the American Association for Cancer ResearchMarch 1, 2021Raj D, Nikolaidi M, Garces I, Lorizio D, Castro NM, Caiafa SG, Moore K, Brown NF, Kocher HM, Duan X, et al.

(3) Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial CellsMBioMarch 14, 2017Klaile E, Müller MM, Schäfer MR, Clauder AK, Feer S, Heyl KA, Stock M, Klassert TE, Zipfel PF, Singer BB, et al.

CEACAM7 (BAC2) Antibody